Comparing the Efficacy and Safety of Vericiguat With Standard Medical Treatment in Heart Failure Patients
Starting soon · Phase 4 · Has a placebo group
Conditions studied: Heart Failure With Reduced Ejection Fraction (HFrEF)
In brief
To compare the effectiveness and safety of Vericiguat with Standard Medical Treatment in Patients with Heart Failure and Reduced Ejection Fraction
Key facts
- Study ID
- NCT07697833
- Run by
- National Institute of Cardiovascular Diseases, Pakistan
- People needed
- 500
- Starts
- 2026-07-15
- Expected to finish
- 2027-07-31
- Last updated by the study team
- 2026-07-13
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age >18 years of any gender
- Chronic heart failure (New York Heart Association [NYHA] functional class II, III, or IV), a reduced left ventricular ejection fraction of less than 45% within 12 months before randomization
- Elevated natriuretic peptide level: (For patients in sinus rhythm, the criteria include a plasma B-type natriuretic peptide (BNP) level of at least 300 pg per milliliter or an NT-proBNP level of at least 1000 pg per milliliter. For patients in atrial fibrillation, the criteria included a BNP level of at least 500 pg per milliliter or an NT-proBNP level of at least 1600 pg per milliliter).
- Evidence of worsening heart failure.
- The percentage of enrolled patients with an estimated glomerular filtration rate of 15 to 30 ml per minute per 1.73 m2 of body-surface area was capped at 15%.
- Patients on guideline-based medical therapy 3 months
- Written and informed consent.
You may not qualify if…
- Systolic blood pressure of less than 100 mm Hg.
- Concurrent or anticipated use of long-acting nitrates.
- Use of intravenous inotropes or implantable left ventricular assist devices.
- Not on standard of care medical treatment for heart failure.
- Unwillingness to give consent
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.